|
UA71994C2
(en)
|
1999-08-31 |
2005-01-17 |
Kissei Pharmaceutical |
Glucopyranosyloxypyrazole derivatives, a pharmaceutical composition containing these derivatives and intermediate compounds for the preparation thereof
|
|
US6515117B2
(en)
|
1999-10-12 |
2003-02-04 |
Bristol-Myers Squibb Company |
C-aryl glucoside SGLT2 inhibitors and method
|
|
PH12000002657B1
(en)
|
1999-10-12 |
2006-02-21 |
Bristol Myers Squibb Co |
C-aryl glucoside SGLT2 inhibitors
|
|
AU2002223127A1
(en)
|
2000-11-30 |
2002-06-11 |
Kissei Pharmaceutical Co., Ltd. Intellectual Property |
Glucopyranosyloxybenzyl benzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
|
|
SI1354888T1
(sl)
|
2000-12-28 |
2009-10-31 |
Kissei Pharmaceutical |
Glukopiranoziloksipirazolni derivati in njihova uporaba v zdravilih
|
|
BR0308653A
(pt)
|
2002-03-22 |
2005-02-15 |
Kissei Pharmaceutical |
Cristais de derivado de benzeno de glicopiranosiloxibenzila
|
|
DE10231370B4
(de)
|
2002-07-11 |
2006-04-06 |
Sanofi-Aventis Deutschland Gmbh |
Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel
|
|
CN1802366B
(zh)
|
2003-03-14 |
2010-12-22 |
安斯泰来制药有限公司 |
C-糖苷衍生物及其盐
|
|
MXPA06001274A
(es)
|
2003-08-01 |
2006-04-11 |
Tanabe Seiyaku Co |
Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio.
|
|
EP2360165A3
(de)
|
2004-03-16 |
2012-01-04 |
Boehringer Ingelheim International GmbH |
Glucopyranosyl-substituierte Benzol-Derivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
TW200637839A
(en)
|
2005-01-07 |
2006-11-01 |
Taisho Pharmaceutical Co Ltd |
1-thio-d-glucitol derivatives
|
|
TW200637869A
(en)
|
2005-01-28 |
2006-11-01 |
Chugai Pharmaceutical Co Ltd |
The spiroketal derivatives and the use as therapeutical agent for diabetes of the same
|
|
UA91546C2
(uk)
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
US7772191B2
(en)
|
2005-05-10 |
2010-08-10 |
Boehringer Ingelheim International Gmbh |
Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
|
|
AU2007216452A1
(en)
|
2006-02-15 |
2007-08-23 |
Boehringer Ingelheim International Gmbh |
Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
|
|
US7803778B2
(en)
|
2006-05-23 |
2010-09-28 |
Theracos, Inc. |
Glucose transport inhibitors and methods of use
|
|
US7919598B2
(en)
|
2006-06-28 |
2011-04-05 |
Bristol-Myers Squibb Company |
Crystal structures of SGLT2 inhibitors and processes for preparing same
|
|
TWI499414B
(zh)
|
2006-09-29 |
2015-09-11 |
Lexicon Pharmaceuticals Inc |
鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法
|
|
UY30730A1
(es)
|
2006-12-04 |
2008-07-03 |
Mitsubishi Tanabe Pharma Corp |
Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
|
|
US7846945B2
(en)
|
2007-03-08 |
2010-12-07 |
Lexicon Pharmaceuticals, Inc. |
Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use
|
|
AR065809A1
(es)
|
2007-03-22 |
2009-07-01 |
Bristol Myers Squibb Co |
Formulaciones farmaceuticas que contienen un inhibidor sglt2
|
|
ES2375800T3
(es)
|
2007-07-26 |
2012-03-06 |
Lexicon Pharmaceuticals, Inc. |
Métodos y compuestos útiles para la preparación de inhibidores de cotransportador 2 de sódio-glucosa.
|
|
CN101801371B
(zh)
|
2007-09-10 |
2012-11-28 |
詹森药业有限公司 |
可用作sglt抑制剂的化合物的制备方法
|
|
TW201011043A
(en)
|
2008-06-20 |
2010-03-16 |
Chugai Pharmaceutical Co Ltd |
Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
|
|
TWI472521B
(zh)
|
2008-07-17 |
2015-02-11 |
Lexicon Pharmaceuticals Inc |
（２ｓ，３ｒ，４ｒ，５ｓ，６ｒ）－２－（４－氯－３－（４－乙氧苄基）苯基）－６－（甲硫）四氫－２ｈ－哌喃－３，４，５－三醇的固體形態與其使用方法
|
|
MX2011002166A
(es)
|
2008-08-28 |
2011-04-07 |
Pfizer |
Derivados de dioxa-biciclo[3.2.1]octano-2,3,1-triol.
|
|
MX345494B
(es)
|
2009-02-13 |
2017-02-02 |
Boehringer Ingelheim Int Gmbh * |
Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, dosificación farmacéutica de la misma, procesos para su preparación y usos de la misma para el control glucemico mejorado en un paciente.
|
|
MY161472A
(en)
*
|
2009-02-13 |
2017-04-14 |
Boehringer Ingelheim Int |
Sglt-2 inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance or hyperglycemia
|
|
PL2395983T3
(pl)
*
|
2009-02-13 |
2020-09-07 |
Boehringer Ingelheim International Gmbh |
Kompozycja farmaceutyczna zawierająca inhibitor sglt2, inhibitor dpp-iv i ewentualnie dalszy środek przeciwcukrzycowy oraz jej zastosowania
|
|
PL2419097T3
(pl)
|
2009-04-16 |
2014-02-28 |
Taisho Pharmaceutical Co Ltd |
Kompozycja farmaceutyczna zawierająca (1S)-1,5-anhydro-1-[5-(4-etoksybenzylo)-2-metoksy-4-metylofenylo]-1-tio-D-glucitol i metforminę oraz jej zastosowanie w leczeniu cukrzycy
|
|
BR112012007085B8
(pt)
|
2009-09-30 |
2021-05-25 |
Boehringer Ingelheim Int |
processos para a preparação de derivados de benzil-benzeno substituídos com glicopiranosila
|
|
HUE029381T2
(en)
|
2009-09-30 |
2017-02-28 |
Boehringer Ingelheim Int |
Method for the preparation of a crystalline form of 1-chloro-4-(beta-d-glucopyranos-1-yl)-2-(4-((s)-tetrahydrofuran-3-yloxy)benzyl)benzene
|
|
WO2014123749A1
(en)
*
|
2013-01-30 |
2014-08-14 |
Board Of Regents Of The University Of Nebraska |
Compositions and methods for treating complications associated with diabetes
|
|
US20180021341A1
(en)
*
|
2015-01-09 |
2018-01-25 |
Gilead Apollo, Llc |
Acc inhibitor combination therapy for the treatment of non-alcoholic fatty liver disease
|
|
EP3455216B1
(en)
*
|
2016-05-12 |
2020-11-04 |
Boehringer Ingelheim International GmbH |
Pyridinyl derivatives, pharmaceutical compositions and uses thereof as aoc3 inhibitors
|